EU pharma reform: Belgium risks losing its life sciences edge, lawyer warns

EURACTIV - The EU's pharmaceutical reforms are not law yet, but for Belgium, the cost of waiting is already real. The pharma package faces a final vote this autumn, and most rules only bite around 2028, while the Critical Medicines Act could apply soon after 2026.  Read more

Eline D'Joos, Crowell & Moring LLP (photo courtesy of Crowell & Moring LLP)